Cited by 236Acute Myeloid Leukemia ResearchEpigenetics and DNA MethylationHematopoietic Stem Cell Transplantation

The DOI matches its Crossref record; 86 of the 87 references it cites were found in a registry or an index, and 1 are not checked yet.

DNA methylation disruption reshapes the hematopoietic differentiation landscape

Open access

Abstract

Mutations in genes involved in DNA methylation (DNAme; for example, TET2 and DNMT3A) are frequently observed in hematological malignancies 1-3 and clonal hematopoiesis 4,5. Applying single-cell sequencing to murine hematopoietic stem and progenitor cells, we observed that these mutations disrupt hematopoietic differentiation, causing opposite shifts in the frequencies of erythroid versus myelomonocytic progenitors following Tet2 or Dnmt3a loss. Notably, these shifts trace back to transcriptional priming skews in uncommitted hematopoietic stem cells. To reconcile genome-wide DNAme changes with specific erythroid versus myelomonocytic skews, we provide evidence in support of differential sensitivity of transcription factors due to biases in CpG enrichment in their binding motif. Single-cell transcriptomes with targeted genotyping showed similar skews in transcriptional priming of DNMT3A-mutated human clonal hematopoiesis bone marrow progenitors. These data show that DNAme shapes the topography of hematopoietic differentiation, and support a model in which genome-wide methylation changes are transduced to differentiation skews through biases in CpG enrichment of the transcription factor binding motif.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41588-020-0595-4

Cites

86 of 87 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 86 references

Cited by

Sorted by citations

See all 236

Metadata

Authors
Izzo, F., Lee, S. C., Poran, A., Chaligne, R., Gaiti, F., Gross, B., Murali, R. R., Deochand, S. D., Ang, C., Jones, P. W., Nam, A. S., Kim, K.-T., Kothen-Hill, S., Schulman, R. C., Ki, M., Lhoumaud, P., Skok, J. A., Viny, A. D., Levine, R. L., Kenigsberg, E., Abdel-Wahab, O., & Landau, D. A.
Affiliations
  • New York Genome Center (US)
  • Memorial Sloan Kettering Cancer Center (US)
  • Weill Cornell Medicine (US)
  • NYU Langone Health (US)
  • Icahn School of Medicine at Mount Sinai (US)
Corresponding author
Landau, Dan A.
Venue
Nature Genetics
Published
2020-03-23
Volume
52
Issue
4
Pages
378-387
ISSN
  • 1061-4036 (ISSN-L)
  • 1546-1718
OpenAlex
W3012899267
Cited by
236
References
86
Citations by year
2026: 16 · 2025: 25 · 2024: 46 · 2023: 42 · 2022: 45 · 2021: 38 · 2020: 24
FWCI
23.53
Type
journal article
Language
en
Open access
Locations
  • Nature Genetics (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • Burroughs Wellcome Fund
  • Pershing Square Foundation
  • Foundation for the National Institutes of Health (DP2-CA239065)
  • EIF | Stand Up To Cancer (SU2C-AACR-IRG-0616)
  • American Society of Hematology
  • Marie Skłodowska-Curie
  • National Cancer Center
  • U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI R00 CA218896, K08 CA215317)
  • U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (1R35GM122515)
  • Damon Runyon Cancer Research Foundation (DRG 117-15)
  • Edward P. Evans Foundation
  • Leukemia and Lymphoma Society
  • U.S. Department of Health & Human Services | National Institutes of Health (P30 CA008748)
Topics
  • Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
  • Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
Keywords
DNA methylation, hematopoietic differentiation, TET2, DNMT3A, clonal hematopoiesis, hematologic malignancies, hematopoietic stem cells, erythroid progenitor cells, transcriptional priming, transcription factor binding motifs, single-cell transcriptomics, targeted genotyping
MeSH terms
Animals, Cell Differentiation, DNA (Cytosine-5-)-Methyltransferases, DNA-Binding Proteins, Hematopoiesis, Hematopoietic Stem Cells, Humans, Male, Mice, Transgenic, Mutation, Transcription, Genetic, DNA Methylation, Mice, Transcriptome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review